ASTRO 2017: Highlights in Advanced Lung Cancer
This video highlights studies on advanced lung cancer with practice-changing potential presented at the 2017 ASTRO Annual Meeting.
ASTRO 2017: Practice-Changing Abstracts in Prostate, Renal Cancers
This video highlights potentially practice-changing studies on genitourinary cancers presented at the 2017 ASTRO Annual Meeting.
ASTRO 2017: Updates in HPV-Positive Head and Neck Cancer
This video highlights studies on HPV-positive head and neck cancer presented at the 2017 ASTRO Annual Meeting.
ASTRO 2017: Aggressive Therapy Fails in High-Risk Endometrial Cancer
This video reviews results of a phase III trial that compared pelvic radiation therapy vs vaginal cuff brachytherapy plus chemotherapy in patients with early-stage, high-risk endometrial cancer.
PRO: Treatment Intensification in Poor Prognosis Germ Cell Tumors
In this video, Dr. Fizazi argues for treatment intensification for poor-prognosis germ cell tumor patients who display unfavorable marker decline.
CON: Treatment Intensification in Poor Prognosis Germ Cell Tumors
In this video, Dr. Bosl argues against treatment intensification for poor-prognosis germ cell tumor patients who display unfavorable marker decline.
Long- vs Short-Course Radiation Therapy in Rectal Cancer
This video reviews some of the pros and cons of long-course and short-course radiation therapy for the neoadjuvant treatment of rectal cancer.
Tools, Biomarkers Needed to Identify Immune-Related Toxicities
This video reviews the need for biomarkers and tools that could identify those at high risk of immune-related toxicities among patients undergoing immunotherapy treatment.
Using Patient Variables in CML to Guide Treatment
This video highlights patient variables, including kidney function or history of diabetes, that can help guide treatment in chronic myeloid leukemia.
Role of Surgery in Mesothelioma
This video reviews the role of surgery in the management of patients with mesothelioma.
Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer
This video highlights trials studying the long-term impact of adjuvant tamoxifen and aromatase inhibitors for the treatment of patients with postmenopausal breast cancer.
Impact of SOFT/TEXT in Premenopausal Breast Cancer
This video reviews the impact of the SOFT/TEXT trials for the treatment of patients with premenopausal breast cancer, and ways to best use the results.
Using Molecular Tools to Guide Breast Cancer Treatment
This video examines the use of molecular diagnostics for guiding adjuvant endocrine therapy in patients with breast cancer.
Latest Immunotherapy Approaches in Multiple Myeloma
This video highlights novel approaches using immunotherapies and vaccines for advancing treatment in multiple myeloma.
Surgical Management of Stage III (N2) Lung Cancer
This video reviews the role of surgery in patients with stage III (N2) non–small-cell lung cancer, highlighting some of the challenges in studying these patients and the need for multidisciplinary patient evaluations.
Does Radiotherapy in Unresectable Pancreatic Cancer Add Value?
This video reviews the conflicting data and perspectives regarding the use of radiotherapy in unresectable pancreatic cancer.
Second-Line Therapy Options in Metastatic Renal Cell Carcinoma
This video reviews the various treatment options for metastatic renal cell carcinoma in the second-line setting, including considerations for different toxicity profiles.
First-Line Treatment of Metastatic Renal Cell Carcinoma
This video reviews the first-line treatment of metastatic renal cell carcinoma, including for those patients who are ineligible for interleukin-2.
Tackling Endocrine Resistance in Breast Cancer
This video reviews the mechanisms of acquired and upfront endocrine resistance in estrogen receptor–positive breast cancer as well as research into strategies for overcoming this resistance.
Is Pseudoprogression in Lung Cancer Real?
This video reviews pseudoprogression in non–small-cell lung cancer, including the incidence of this phenomenon and treatment considerations when it arises.